Ghrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex

Area of Science:

• Neuroscience
• Metabolic pathways
• Cellular biology

Background:

• Carnitine palmitoyltransferase 1A (CPT1A) and fatty acid oxidation (FAO) are implicated in ghrelin's hypothalamic actions.
• The role of CPT1A and FAO in ghrelin's effects on the brain cortex remains unexplored.

Purpose of the Study:

• To investigate the region-specific effects of ghrelin on CPT1A activity and GABA metabolism in the mouse brain.
• To elucidate the role of CPT1A in mediating ghrelin's influence on GABA release and mitochondrial function in cortical neurons.

Main Methods:

• Comparative analysis of CPT1A and GABA transaminase (GABAT) activity in hypothalamic and cortical tissues after ghrelin treatment.
• In vitro studies using primary cortical neurons to assess ghrelin's effect on GABA release.
• Utilizing CPT1A floxed mice to genetically ablate CPT1A and observe downstream effects on neuronal function.

Main Results:

• Ghrelin differentially impacts CPT1A activity and GABA metabolism between the hypothalamus and cortex.
• In the cortex, ghrelin reduces both CPT1A and GABAT activity, leading to decreased GABA release.
• Genetic ablation of CPT1A in mice mimics ghrelin's effects on cortical GABA release and mitochondrial function.

Conclusions:

• Ghrelin's modulation of CPT1A activity influences mitochondrial function and GABA metabolism in a region-specific manner within the brain.
• The findings highlight a novel mechanism by which ghrelin exerts differential effects across the central nervous system.
• CPT1A plays a critical role in mediating ghrelin's impact on GABAergic signaling in the cortex.